During the past decade, Fort Wayne Neurological Center conducted 29 clinical trials. In the 10-year time frame, 29 clinical trials started and 17 clinical trials were completed, i.e. on average, 58.6% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 9 clinical trials were completed. i.e. 56.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Fort Wayne Neurological Center" #1 sponsor was "Biogen" with 4 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Genzyme, a Sanofi Company" with 4 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Eisai Inc." with 4 trials sponsored. Other sponsors include 28 different institutions and companies that sponsored additional 33 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Fort Wayne Neurological Center" #1 collaborator was "Bayer" with 4 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "National Institute on Aging (NIA)" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Biogen" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Fort Wayne Neurological Center" are "Multiple Sclerosis" (9 trials), "Alzheimer's Disease" (8 trials), "Multiple Sclerosis, Relapsing-Remitting" (6 trials), "Alzheimer Disease" (3 trials) and "Migraine" (3 trials). Many other conditions were trialed in "Fort Wayne Neurological Center" in a lesser frequency.

Most popular intervention types in "Fort Wayne Neurological Center" are "Drug" (41 trials), "Biological" (9 trials), "Other" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (22 trials), "Interferon beta-1a" (3 trials), "Alemtuzumab 12 mg" (2 trials), "Alemtuzumab 24 mg" (2 trials) and "Cladribine Tablets" (2 trials). Other intervention names were less common.

The vast majority of trials in "Fort Wayne Neurological Center" are 52 trials for "All" genders.

Currently, there are NaN active trials in "Fort Wayne Neurological Center". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Fort Wayne Neurological Center, undefined suspended trials, and 11 terminated clinical trials to date.

Out of the total trials that were conducted in Fort Wayne Neurological Center, 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 0 trials that are defined as “Not Applicable".